HopeStage
Back to all studies
CompletedNCT05757453

Boost mobile behavioral support alongside opioid care

About this title

Read the official source —
Device studyAges 18–65United StatesAddiction
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 65 years.

Listed locations
AstoriaSee all locations and recruitment
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
Study clarity

Study information

Study start dateStarted: April 18, 2022
Recruitment status
Completed
Enrollment listed in the registry
43
Sponsor
NXTech
Sponsor type
Unknown or unclear
Study type
Device
Intervention type
DEVICE
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
Locations
United States
Age range
From 18 Years to 65 Years
Official registry ID
NCT05757453
Official title
Show the full official title

BoostOne Study (MHealth)

Looking for a study you can join?

Explore recruiting studies

Get this study by email

HopeStage may email me about this study.
Loading the security check...

Recruitment & locations

Completed

Astoria

FAQ

Questions about this study

Who is behind this study?

The study sponsor is NXTech.

Who was this study for?

Listed age limits: 18 years to 65 years.

Want to explore more studies?

Explore studies